ENTITY
Biogen Inc

Biogen Inc (BIIB US)

142
Analysis
Health Care • United States
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
more
•21 Oct 2016 14:58

What Happens in Vegas...Goes to the White House (Hillary 2, Trump 1...Game Over!)

A Hillary victory would benefit Thai markets in terms of TIP market re-allocations and export strength, while hurting us on global stability....

•20 Oct 2016 11:25

Recap of Key Events in the U.S. Biotechnology and Pharmaceutical Sector: Mid-Week Update

Galapagos NV (GLPG NA)Ā seems to have got some investor attention after the successful results of Celgene Corp (CELG US)Ā anti-inflammatory product...

•19 Oct 2016 11:19

Recap of Key U.S. Biotechnology and Pharmaceutical Sector Events: October 17

Celgene (NASDAQ: CELG) announced successful phase 1b data of its antisense therapy GED-0301 in theĀ treatment of Crohn's disease (48% remission rate...

•11 Oct 2016 16:59

Strike 2 in St Louis: Trump's Town Hall Trap

Before the Battle.Ā Even before this key 2nd presidential debate in St Louis on October 9 (but October 10 Thai time), the press raised many issues....

bearish•Samsung C&T
•03 Sep 2016 10:22

Bioepis Details Don't Support the Valuation

We are following up on our previous post on the proposed listing of Samsung BioLogics US$9 Billion Valuation Is Rarefied AirĀ Ā in response to...

Share
x